Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Ketrosden Triasmitra Tbk. (KETR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Ketrosden Triasmitra Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp220 (market cap 308B, 111.5K 24h volume), while Ketrosden Triasmitra Tbk. trades at Rp540 (market cap 1.49T, 23.18M 24h volume). The key difference: Ketrosden Triasmitra Tbk. is far larger — about 4.8× Diagnos Laboratorium Utama Tbk.'s market cap, and Ketrosden Triasmitra Tbk. is more actively traded (23.18M versus 111.5K). Which is the better fit depends on your goals.
| DGNS | KETR | |
|---|---|---|
Market Cap | 308B | 1.49T |
Volume | 111.5K | 23.18M |
Lot | 1.12K | 231.77K |
Turnover | 24.73M | 12.61B |
Average Price | 221.78 | 543.94 |
Value | 24.73M | 12.61B |
Indicative Equilibrium Price | 230 | 525 |
Indicative Equilibrium Volume | 110 | 40.8K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Ketrosden Triasmitra Tbk.
PT Ketrosden Triasmitra Tbk was established base on Notarial Deed No.179 of Pudji Redjeki Irawati S.H., dated November 25, 1994.
Read more on KETR →
